Literature DB >> 10533799

T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients.

J Hou1, G K Lau, J Cheng, C C Cheng, K Luo, W F Carman.   

Abstract

BACKGROUND: A double variant in the basal core promoter, converting nucleotide 1762 from A to T (T1762) and nucleotide 1764 from G to A (A[764), has been described in patients with chronic hepatitis B infection. Its prevalence and significance in Chinese chronic HBV carriers are unknown.
METHODS: We studied 177 Chinese patients with chronic HBV infection (chronic hepatitis/asymptomatic: 89/88; hepatitis B e antigen positive/negative: 84/93). The double variant was detected by mismatched polymerase chain reaction and restriction fragment length polymorphism analysis. The reliability of this method was verified by sequencing in 41 serum samples with 100% matching.
RESULTS: The double variant T1762/ A1764 was found in 52 of 89 patients with chronic hepatitis, but in only 6 of 59 asymptomatic carriers (p<0.001). The prevalence was significantly lower in hepatitis B e antigen positive patients (23/84) than in hepatitis B e antigen negative patients (35/64) (p<0.005). Precore variant, A1896 was detected in 40 individuals; 31 of them suffered from chronic hepatitis and 9 were asymptomatic (p<0.001). A combination of both variants T1762/A1764 and A1896 was seen in 3 of 59 asymptomatic and 22 of 89 patients with chronic hepatitis (p<0.005).
CONCLUSIONS: Mismatched polymerase chain reaction with restriction fragment length polymorphism provides a reliable, easy and fast method for detection of the presence of the T1762/A1764 variant. In Chinese chronic hepatitis B carriers, T1762/A1764 variant was associated with both active liver disease and hepatitis B e antigen negativity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533799     DOI: 10.1111/j.1478-3231.1999.tb00070.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  12 in total

1.  Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant.

Authors:  E Alestig; C Hannoun; P Horal; M Lindh
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China.

Authors:  Li Xu; Guoqing Qian; Lili Tang; Jianjia Su; Jia-Sheng Wang
Journal:  J Hepatol       Date:  2010-06-20       Impact factor: 25.083

3.  Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.

Authors:  Alvaro Muñoz; Jian Guo Chen; Patricia A Egner; Melinda L Marshall; Jamie L Johnson; Michael F Schneider; Jian Hua Lu; Yuan Rong Zhu; Jin-Bing Wang; Tao Yang Chen; Thomas W Kensler; John D Groopman
Journal:  Carcinogenesis       Date:  2011-04-07       Impact factor: 4.944

4.  Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes.

Authors:  Xiangdong David Ren; Selena Y Lin; Xiaohe Wang; Tianlun Zhou; Timothy M Block; Ying-Hsiu Su
Journal:  J Virol Methods       Date:  2009-01-31       Impact factor: 2.014

5.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Lian-Ying Ge; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Xue-Yan Wang; Tim J Harrison
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

7.  Specific mutations of hepatitis B virus in plasma predict liver cancer development.

Authors:  Shuang-Yuan Kuang; Peta E Jackson; Jin-Bing Wang; Pei-Xing Lu; Alvaro Muñoz; Geng-Sun Qian; Thomas W Kensler; John D Groopman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

8.  Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.

Authors:  Jian-Min Yuan; Alex Ambinder; Yunhua Fan; Yu-Tang Gao; Mimi C Yu; John D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

9.  Precore and core promoter mutations of the hepatitis B virus gene in chronic genotype C-infected children.

Authors:  Hyun Sik Kang; Ki Soo Kang; Byung-Cheol Song
Journal:  J Korean Med Sci       Date:  2011-03-28       Impact factor: 2.153

10.  HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.

Authors:  Yueming Chen; Daojun Yu; Weiying Zhang; Chunning Qiu; Guoqian Xiang; Weijian Dai; Shenghai Wu; Xianjun Wang
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.